BillionToOne, Inc. (BLLN) - Stock Analysis

Key Financial Insights: • Strong liquidity • Weak profitability • Extremely high multiples BLLN has a strong cash position, gross margins and liquidity but is burdened by weak net margins, heavy operating/R&D spend, a large accumulated deficit and extremely rich valuation multiples that imply expected growth not yet realized. #cash-rich‍

Key Price Behavior Insights: • Up ~9.9% • Above last-month SMA • High intra-month volatility Support Level: $69.1–$71.4 Resistance Level: $82.9–$83.1 BLLN has risen about 9.9% over the last month and trades well above its last-month average with support near $69.1–$71.4 and resistance at $82.9–$83.1, although ~15% intra-period swings create volatility risk and a break below the last-month average and $69–$71 would weaken the bullish case.

Key News Insights: • Revenue acceleration • Profitability achieved • Oncology leadership BillionToOne beat Q4 expectations with sales up 113% to $96.1M and profitability, raised 2026 revenue guidance to $430–$445M, triggered heavy trading, and added oncology leadership to support diversification.